Axitinib Cost & Price and Brands

Axitinib is a tyrosine kinase inhibitor used to treat advanced renal cell carcinoma (RCC). It works by blocking enzymes that promote cancer cell growth and angiogenesis, helping to manage tumor progression. The Medicine is taken by mouth and it works best for patients who didn’t improve by other treatments. Axitinib’s specific action targets RCC directly, aiding in the fight against the cancer. This provides doctors with an additional method to treat this difficult condition.

Available Brands and Axitinib Price List:

The Brand name of the Axitinib Generic:

The generic medicine Axitinib is sold under the brand name Inlyta. Doctors use it as a targeted therapy to treat advanced renal cell carcinoma (RCC). It specifically inhibits certain proteins known as tyrosine kinases, which play a crucial role in the growth and spread of cancer cells.

Now most companies have been producing Axitinib generic with different brands’ names. Like, Beacon Pharmaceuticals Limited manufactures Axinix.

Axitinib 1 MG

1 mg is a prescription medicine mainly used to treat advanced kidney cancer in patients who have already had other treatments. It helps manage the disease after those treatments do not work well. Each film-coated tablet contains 1 mg of Axitinib, a potent tyrosine kinase inhibitor that works by blocking specific enzymes involved in cancer cell growth and blood vessel formation. This targeted approach helps to slow down or stop the progression of the disease. 

Axitinib 5 MG

5 mg is a prescription medication indicated for the treatment of advanced renal cell carcinoma (RCC) in patients who have not responded adequately to previous systemic therapies. Each film-coated tablet contains 5 mg of Axitinib, a selective tyrosine kinase inhibitor that targets enzymes involved in cancer cell proliferation and angiogenesis. By disrupting these pathways, it helps to slow tumor growth and improve patient outcomes.

Side Effects

If you have any of these problems, please talk to your doctor:

1. High blood pressure
2. Fatigue
3. Diarrhea
4. Nausea and vomiting
5. Loss of appetite
6. Hand-foot syndrome
7. Mouth sores
8. Changes in liver function
9. Skin rash

FDA Approval

Axitinib was approved by the FDA in January 2012, to treat advanced renal cell carcinoma (RCC) in patients who have already had one other treatment. This approval came after clinical trials showed that Axitinib is effective in slowing down the cancer and helping patients live longer.

Clinical Trial

In April 2019, the Food and Drug Administration (FDA) approved pembrolizumab, known as KEYTRUDA, along with axitinib. Doctors use this combination for the first treatment of patients with advanced kidney cancer. The approval allows doctors to offer this effective option to help manage the disease.

In May 2019, the Food and Drug Administration (FDA) approved avelumab, also called BAVENCIO. It is to be used in combination with axitinib for treating advanced renal cell carcinoma. This combination is intended for the first treatment of patients with advanced kidney cancer. The approval provides another option for doctors to help manage this serious condition.

Axitinib package insert

FAQ Section of Axitinib Generic

1. How much does Axitinib cost?

Ans: The cost of Axitinib typically starts from $160 for a 30-day supply without insurance in the United States.

2. Who makes Axitinib?

Ans: It is manufactured by Pfizer Inc.

3. Where is Axitinib made?

Ans: Primarily, it is made in the United States and Ireland.

4. Is Axitinib a cancer medicine?

Ans: Yes, It is a cancer medicine used to treat advanced kidney cancer called renal cell carcinoma (RCC).

Feel Free You can Contact on WhatsApp or WeChat

Visit Our Shop for More Related Medicine